Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia
      Description

      This was a multicenter, Phase 1, standard 3+3 dose-escalation study to evaluate the safety and anti-neoplastic activity of moxetumomab pasudotox in relapsed or refractory participants with chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL) or Small Lymphocytic Lymphoma (SLL).

      Conditions
      Leukemia, Lymphoma, Chronic LymphocyticLeukemia, Prolymphocytic Leukemia, SmallLymphocytic Lymphoma, Moxetumomab Pasudotox
      Talk to us
      TERMINATED
      Study in Pediatrics With Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia (pALL) or Lymphoblastic Lymphoma
      Description

      The primary objective of this study is to evaluate the efficacy of moxetumomab pasudotox in pediatric participants with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL) or B-cell lymphoblastic lymphoma.

      Conditions
      B-Cell Pediatric ALL
      Talk to us